Tecovirimat Monohydrate

CHEBI:CHEBI_752587

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2602131
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
listing_expiration_date
20251231
dosage_form
INJECTION, SOLUTION, CONCENTRATE
nui
N0000193857
pharm_class_moa
Breast Cancer Resistance Protein Inhibitors [MoA]
pharm_class
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]
active_ingredient_strength
5 kg/5kg
route
INTRAVENOUS
marketing_start_date
20220531
package_marketing_start_date
20-SEP-23
labeler_name
SIGA Technologies, Inc.
generic_name
tecovirimat monohydrate
product_ndc
14335-680
spl_id
0bcfc172-bb18-5db9-e063-6394a90a9a9e
active_ingredient_name
TECOVIRIMAT
package_ndc
14335-680-01
package_description
5 kg in 1 DRUM (14335-680-01)
brand_name
TPOXX
brand_name_base
TPOXX
application_number
NDA214518
manufacturer_name
SIGA Technologies, Inc.
unii
SB96YO2BR8
spl_set_id
fce826ab-4d6a-4139-a2ee-a304a913a253
upc
0350072200427
pharm_class_epc
Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class